mifepristone

Lawyers and justices spent much of the hearing discussing whether the group that brought the challenge had legal standing.

If it rules in favor of the Alliance of Hippocratic Medicine, pregnant women’s access to mifepristone could be limited.

Two of the retracted studies were cited by a judge in a case that could see the abortion pill recalled.

The argument comes as the court prepares to hear the most significant abortion-related case since it overturned Roe v. Wade in 2022.

The Court will hear the case on March 26 in the most significant abortion-related case since it overturned Roe v. Wade in 2022.

Involving relaxed restrictions on mifepristone (RU-486) , this is the most important abortion-related case since the June 2022 Dobbs ruling.

The court has not yet scheduled oral arguments in the contentious case.

The nation’s top court will decide if abortion pill mifepristone is too dangerous to use, after the FDA removed safety precautions.

The court agreed to take a look at policies related to medication abortions.

The justices were supposed to consider three related petitions on Dec. 8, but failed to make a decision in the closely watched cases on Dec. 11.

Several Republican attorneys general have filed a lawsuit against the Food and Drug Administration, alleging unlawful approval of chemical abortion drugs.

Lorna Green said she opposed abortion but expressed regret for setting fire to the abortion clinic, which also offers ‘gender-affirming care.’

An abortion pill manufacturer has petitioned the U.S. Supreme Court to examine whether a federal appeals court erred in upholding a preliminary injunction.

A New Orleans-based appeals court has ruled to restrict access to the abortion pill mifepristone, partially upholding a lower court ruling that alarmed abortion advocates but won praise from pro-life groups.